InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Ruff Shamim, 董事. Officer active across 1 company, notably Reata Pharmaceuticals INC. Cumulatively, 6 disclosures have been recorded. Activity tracked since 3 January 2022. The latest transaction was disclosed on 28 July 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Ruff Shamim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
7,359 股Class A common stockSEC:0000899243-23-019539:0
1,250 股@ US$92.2053.8% 占其流量Class A common stockSEC:0001209191-23-044004:0
454 股@ US$93.6120.3% 占其流量Class A common stockSEC:0001209191-23-035879:0
199 股@ US$27.322.6% 占其流量Class A common stockSEC:0001209191-23-018231:0
1,222 股@ US$34.7620.6% 占其流量Class A common stockSEC:0001209191-22-035423:0
118 股@ US$27.321.5% 占其流量Class A common stockSEC:0001209191-22-001627:0
6 条申报中的 6 条
About Ruff Shamim
Ruff Shamim is Administrateur at Reata Pharmaceuticals INC (XNAS). He has 6 filings in total, and across the 6 recent filings held, the transactions run from 2022-01-05 to 2023-09-26, with attribution as the modal transaction nature.
